Compounds > n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide
Page last updated: 2024-10-28

n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide and Drug Withdrawal Symptoms

n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide has been researched along with Drug Withdrawal Symptoms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tokuyama, S1
Feng, Y1
Wakabayashi, H1
Ho, IK1
Valverde, O1
Tzavara, E1
Hanoune, J1
Roques, BP1
Maldonado, R1

Other Studies

2 other studies available for n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide and Drug Withdrawal Symptoms

ArticleYear
Possible involvement of protein kinases in physical dependence on opioids: studies using protein kinase inhibitors, H-7 and H-8.
    European journal of pharmacology, 1995, Sep-15, Volume: 284, Issue:1-2

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Behavior, Animal; Butorphanol; Cytosol; Enzy

1995
Protein kinases in the rat nucleus accumbens are involved in the aversive component of opiate withdrawal.
    The European journal of neuroscience, 1996, Volume: 8, Issue:12

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenylyl Cyclases; Animals; Avoidance Learning; Behav

1996